Atlas Trials

Study of Neoadjuvent Chemotherapy Followed by SBRT in Patients With Resectable and Borderline Resectable Pancreatic Cancer

Clinical trial NCT04130399 · WITHDRAWN

Trial details

NCT number
NCT04130399
Sponsor
Indiana University
Status
WITHDRAWN
Phase
Phase 2
Study type
INTERVENTIONAL
Pancreatic CancerPancreatic Adenocarcinoma
Start date
2019-07-01
Primary completion
2022-01-01
Enrollment
0

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.